Japan's Ministry To Establish New Centers To Support Joint Overseas Clinic Trials
This article was originally published in PharmAsia News
Executive Summary
To support joint clinic trials on new drugs between domestic medical facilities and overseas partners, Japan's Ministry of Health, Labor and Welfare announced Sept. 8 plans to establish several research centers to handle issues such as drafting English clinic trial contracts and conducting ethics review based on international standards to protect patients. MHLW has requested a ¥600 million budget for the plan. The plan aims to reduce the cost burden on Japanese domestic medical facilities and increase joint clinic trials with overseas counterparts to promote earlier commercialization of new drugs. (Click here for more - Japanese language
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.